Bengaluru, March 14 (IANS) A 68-year-old man battling Parkinson’s along with life-threatening co-morbidities has been successfully treated by doctors here.
Fortis Hospital, Bannerghatta Road, in a statement on Thursday said that for the first time in India, the NeuroSmart Portable MER system — an advancement of the Deep Brain Stimulation (DBS) therapy — was used to treat a Parkinson’s patient.
“The technology represents a significant leap in Deep Brain Stimulation (DBS) therapy and has advanced target localisation capabilities, automatic navigation, and connectivity tools for offering unparalleled precision in brain analysis,” they noted.
The system lets doctors see how the patient is responding to the treatment in real-time, which makes the surgery more accurate.
The patient, Prakash, had been battling Parkinson’s for about six months.
The neurodegenerative disorder caused stiffness in his arms and legs, making it hard for him to move around and do everyday things. He also partially lost his voice, and sometimes his head and neck would move involuntarily.
Besides, Prakash also had other health issues like high blood pressure and diabetes, and he had undergone surgeries on his heart, spine, and a hernia in the past. The new NeuroSmart Portable MER system helped him to a remarkable recovery.
“The patient is doing well. His tremors have stopped, and his movements have improved. He is now able to do all his activities independently. His medication has also been reduced,” Dr. Raghuram G, Additional Director-Neurosurgery, Fortis Hospital, Bannerghatta Road, Bengaluru, told IANS.
He was discharged just five days post-surgery, the doctor said.
“During the procedure, which is known as Microelectrode Recording (MER), we engage the patient in active motor and speech tasks while he or she remains awake. This interactive approach enhances neurophysiological mapping of the target area, ensuring precise localisation for Deep Brain Stimulation (DBS) electrode placement,” said Dr. Raghuram, in the hospital statement.
“By integrating functional mapping with MER, we meticulously identify the optimal region within the target nucleus. Utilising the advanced AI capabilities of NeuroSmart, we meticulously analyse neuronal recordings in real time. This sophisticated analysis allows us to discern the precise area for electrode placement, ensuring optimal therapeutic efficacy and minimising potential side effects for our patients,” he added.
–IANS
rvt/pgh
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
